Cell>Point LLC
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2001-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://cellpointweb.com
Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2013-07-16
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Cell>Point LLC
- Target Recruit Count
- 60
- Registration Number
- NCT01899833
- Locations
- 🇺🇸
Tom Hennebry, MD, Oklahoma City, Oklahoma, United States
A Single Center Study to Establish the Imaging Protocol of 99mTc-EC-DG in Evaluating the Presence and Severity of Coronary Artery Disease (CAD)
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2013-01-29
- Last Posted Date
- 2013-07-12
- Lead Sponsor
- Cell>Point LLC
- Target Recruit Count
- 2
- Registration Number
- NCT01778218
- Locations
- 🇺🇸
Cardiovascular Imaging Technologies, Kansas City, Kansas, United States
A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Drug: 18 F FDG followed by PET/CT imagingDrug: (99m Tc) ECDG (Ethylenedicysteine-Deoxyglucose)
- First Posted Date
- 2011-07-14
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Cell>Point LLC
- Target Recruit Count
- 154
- Registration Number
- NCT01394679
- Locations
- 🇺🇸
Decatur Memorial Hospital, Decatur, Illinois, United States
Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Cell>Point LLC
- Target Recruit Count
- 22
- Registration Number
- NCT00865319
- Locations
- 🇺🇸
Baptist Health South Florida, Coral Gables, Florida, United States
🇺🇸Decatur Memorial Hospital Department of Radiology, Decatur, Illinois, United States
🇺🇸John Hopkins University, Baltimore, Maryland, United States
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Cell>Point LLC
- Target Recruit Count
- 4
- Registration Number
- NCT00864110
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸Mayo Clinic, Division of Nuclear Medicine, Rochester, Minnesota, United States
🇺🇸Montefiore Medical Center, Bronx, New York, United States